Track topics on Twitter Track topics that are important to you
5412 Irvimg Avenue South
United States of America
Arrowhead’s RNAi toxicity setback in 2016 gave it a jumpstart on a safer and more versatile platform.
(Karger Publishers) Karger Publishers has opened a new Regional Office in Dubai to extend its network in the Middle East. With this local presence, institutions and editors will get direct access to K...
Arrowhead Pharmaceuticals has completed patient enrolment in the Phase l AROAAT1001 trial of ARO-AAT for Treatment of Alpha-1 Liver Disease....Read More... The post Arrowhead ends enrolment in AROAAT1...
Arrowhead Pharmaceuticals' third-generation RNA interference therapy candidate ARO-HBV decreased circulating hepatitis B viru -More-
US-based Arrowhead Pharmaceuticals has completed dosing patients in a Phase I clinical trial (AROAAT1001) of drug candidate ARO-AAT for the...Read More... The post Arrowhead concludes dosing in Phase ...
At the 2018 European Association for the Study of the Liver (EASL) International Liver Congress (ILC), Arrowhead Pharmaceuticals presented positive...Read More... The post Arrowhead’s hepatitis B pr...
(Karger Publishers) Karger Publishers, a globally active medical and scientific publishing company, partners with BenchSci, a life science machine learning startup, to help scientists find biological ...
Arrowhead Pharmaceuticals on Thursday made public select initial data from an early-stage clinical study of a hepatitis B drug it’s developing, sending the company’s stock price (NASDAQ: ARWR) to ...
These highlights do not include all the information needed to use ARIMIDEX safely and effectively. See full prescribing information for ARIMIDEX. Initial U.S. Approval: 1995
These highlights do not include all the information needed to use ARIMIDEX safely and effectively. See full prescribing information for ARIMIDEX. ARIMIDEX® (anastrozole) tablet for oral use Initial U...
Predatory publishers solicit manuscripts through e-mail invitations to potential authors, with the goal of enticing authors to submit a manuscript to the journal. This descriptive study examined the c...
Predatory publishing is an exploitative fraudulent open-access publishing model that applies charges under the pretense of legitimate publishing operations without actually providing the editorial ser...
Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis...
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronic...
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes...
We have published hundreds of Arrowhead Publishers news stories on BioPortfolio along with dozens of Arrowhead Publishers Clinical Trials and PubMed Articles about Arrowhead Publishers for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arrowhead Publishers Companies in our database. You can also find out about relevant Arrowhead Publishers Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...